These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic. Kawasaki T, Kaida T, Arnout J, Vermylen J, Hoylaerts MF. Thromb Haemost; 1999 Feb; 81(2):306-11. PubMed ID: 10064011 [Abstract] [Full Text] [Related]
4. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. O'Donnell J, Tuddenham EG, Manning R, Kemball-Cook G, Johnson D, Laffan M. Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386 [Abstract] [Full Text] [Related]
5. Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism. Mello TB, Siqueira LH, Montavão SA, Ozello MC, Annichino-Bizzacchi JM. Thromb Res; 2008 May; 121(5):625-9. PubMed ID: 17889283 [Abstract] [Full Text] [Related]
8. Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism. Berger M, Moscatelli H, Kulle B, Luxembourg B, Blouin K, Spannagl M, Lindhoff-Last E, Schambeck CM. Thromb Haemost; 2008 May; 99(5):905-8. PubMed ID: 18449420 [Abstract] [Full Text] [Related]
9. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease. Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA. Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936 [Abstract] [Full Text] [Related]
10. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors. Sallai KK, Nagy E, Bodó I, Mohl A, Gergely P. Scand J Rheumatol; 2007 Mar; 36(3):198-205. PubMed ID: 17657674 [Abstract] [Full Text] [Related]
11. A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance. Berntorp E, Archey W, Auerswald G, Federici AB, Franchini M, Knaub S, Kreuz W, Lethagen S, Mannucci PM, Pollmann H, Scharrer I, Hoots K. Eur J Haematol Suppl; 2008 May; (70):3-35. PubMed ID: 18380871 [Abstract] [Full Text] [Related]
12. Factor VIII expression in liver disease. Hollestelle MJ, Geertzen HG, Straatsburg IH, van Gulik TM, van Mourik JA. Thromb Haemost; 2004 Feb; 91(2):267-75. PubMed ID: 14961153 [Abstract] [Full Text] [Related]
13. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z. Acta Haematol; 2009 Feb; 121(2-3):119-27. PubMed ID: 19506358 [Abstract] [Full Text] [Related]
14. Laboratory diagnosis and molecular classification of von Willebrand disease. Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ. Acta Haematol; 2009 Feb; 121(2-3):71-84. PubMed ID: 19506352 [Abstract] [Full Text] [Related]
15. Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis. Nossent AY, Eikenboom JC, Vos HL, Bakker E, Tanis BC, Doggen CJ, Bertina RM, Rosendaal FR. Thromb Haemost; 2006 Jun; 95(6):942-8. PubMed ID: 16732372 [Abstract] [Full Text] [Related]
20. Haemostatic changes and acquired activated protein C resistance in normal pregnancy. Mahieu B, Jacobs N, Mahieu S, Naelaerts K, Vertessen F, Weyler J, Jacquemyn Y, Van der Planken M. Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957 [Abstract] [Full Text] [Related] Page: [Next] [New Search]